Search results
Results From The WOW.Com Content Network
Clotrimazole, sold under the brand name Lotrimin, among others, is an antifungal medication. [2] It is used to treat vaginal yeast infections, oral thrush, diaper rash, tinea versicolor, and types of ringworm including athlete's foot and jock itch. [2] It can be taken by mouth or applied as a cream to the skin or in the vagina. [2]
Butenafine, sold under the brand names Lotrimin Ultra, Mentax, and Butop (In India only), is a synthetic benzylamine derived antifungal drug. It is structurally related to the allylamine antifungals terbinafine & naftifine .
Common side effects include paresthesia, rash, edema, and secondary infections. [1] In 2022, it was the 242nd most commonly prescribed medication in the United States, with more than 1 million prescriptions. [3] [4]
It is applied to the skin or vagina as a cream or ointment. [2] [3] Common side effects include itchiness or irritation of the area in which it was applied. [2] Use in pregnancy is believed to be safe for the baby. [4] Miconazole is in the imidazole family of medications. [2]
Tinea incognita, also spelled tinea incognito, is a fungal infection of the skin that generally looks odd for a typical tinea infection. [1] [2] [a] The border of the skin lesion is usually blurred and it appears to have florid growth.
RUB A535 (also known as Antiphlogistine) is a rubefacient introduced in 1919 and manufactured by Church & Dwight in Montreal, Quebec, Canada. [1]A 1914 advertisement. While little known outside of Canada, it is used there for the treatment of tough muscle pain, arthritic pains, rheumatic pains, bursitis, lumbago, etc. [2] [3] Church and Dwight say on their website that nearly all the research ...
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. ...
The topical cream is indicated for treatment of facial hirsutism in women. [1] [18] It is the only topical prescription treatment that slows the growth of facial hair. [19] In clinical studies with Vaniqa, 81% percent of women showed clinical improvement after twelve months of treatment. [20] Positive results were seen after eight weeks. [21]